The contribution of opiate analgesics to the development of infectious complications in burn patients

American Journal of Surgery

Volumn 192, Issue 1, 2006, Pages 82-86

  Schwacha, Martin G ^a   McGwin Jr , Gerald ^a,b   Hutchinson, Charles B ^b   Cross, James M ^b   MacLennan, Paul A ^b   Rue III, Loring W ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b Center for Injury Sciences   (United States)

Author keywords

Immunosuppression; Morphine; Sepsis

Indexed keywords

ANALGESIC AGENT; HYDROMORPHONE; MORPHINE SULFATE; OPIATE; OXYCODONE; PERCOCET; NARCOTIC ANALGESIC AGENT;

ADULT; ARTICLE; BURN; BURN PATIENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG INFORMATION; DRUG USE; FEMALE; HEALTH CENTER; HEALTH SURVEY; HUMAN; INFECTION COMPLICATION; INJURY SEVERITY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG EFFECT; FOLLOW UP; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; INCIDENCE; INJURY SCALE; MIDDLE AGED; RISK FACTOR; UNITED STATES; WOUND INFECTION;

ANALGESICS, OPIOID; BURNS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNE TOLERANCE; INCIDENCE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TRAUMA SEVERITY INDICES; UNITED STATES; WOUND INFECTION;

EID: 33745967110     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2006.01.001     Document Type: Article

References (28)

1. Sheridan R.L. Burn care. results of technical and organizational progress. JAMA 290 (2003) 719-722
2. Schwacha M.G. Macrophages and post-burn immune dysfunction. Burns 29 (2003) 1-14
3. Goebel A., Kavanagh E., Lyons A., et al. Injury induces deficient interleukin-12 production, but interleukin-12 therapy after injury restores resistance to infection. Ann Surg 231 (2000) 253-261
4. Liu L.L., and Gropper M.A. Postoperative analgesia and sedation in the adult intensive care unit. a guide to drug selection. Drugs 63 (2003) 755-767
5. Joranson D.E., Ryan K.M., Gilson A.M., et al. Trends in medical use and abuse of opioid analgesics. JAMA 283 (2000) 1710-1714
6. Roy S., Cain K.J., Charboneau R.G., et al. Morphine accelerates the progression of sepsis in an experimental sepsis model. Adv Exp Med Biol 437 (1998) 21-31
7. Hilburger M.E., Adler M.W., Truant A.L., et al. Morphine induces sepsis in mice. J Infect Dis 176 (1997) 183-188
8. Roy S., and Loh H.H. Effects of opioids on the immune system. Neurochem Res 21 (1996) 1375-1386
9. Prakash S., Fatima T., and Pawar M. Patient-controlled analgesia with fentanyl for burn dressing changes. Anesth Analg 99 (2004) 552-555
10. Criswell K.K., and Gamelli R.L. Establishing transfusion needs in burn patients. Am J Surg 189 (2005) 324-326
11. Ehrlich H.P. Understanding experimental biology of skin equivalent. from laboratory to clinical use in patients with burns and chronic wounds. Am J Surg 187 (2004) 29S-33S
12. Flores L.R., Wahl S.M., and Bayer B.M. Mechanisms of morphine-induced immunosuppression. effect of acute morphine administration on lymphocyte trafficking. J Pharmacol Exp Ther 272 (1995) 1246-1251
13. Roy S., Balasubramanian S., Sumandeep S., et al. Morphine directs T cells toward T(H2) differentiation. Surgery 130 (2001) 304-309
14. Ryan C.M., Schoenfeld D.A., Thorpe W.P., et al. Objective estimates of the probability of death from burn injuries. N Engl J Med 338 (1998) 362-366
15. Guan L., Townsend R., Eisenstein T.K., et al. The cellular basis for opioid-induced immunosuppression. Adv Exp Med Biol 373 (1995) 57-64
16. Flores L.R., Dretchen K.L., and Bayer B.M. Potential role of the autonomic nervous system in the immunosuppressive effects of acute morphine administration. Eur J Pharmacol 318 (1996) 437-446
17. Tracey K.J. The inflammatory reflex. Nature 420 (2002) 853-859
18. Taub D.D., Eisenstein T.K., Geller E.B., et al. Immunomodulatory activity of mu- and kappa-selective opioid agonists. Proc Natl Acad Sci U S A 88 (1991) 360-364
19. Rahim R.T., Meissler Jr. J.J., Cowan A., et al. Administration of mu-, kappa- or delta2-receptor agonists via osmotic minipumps suppresses murine splenic antibody responses. Int Immunopharmacol 1 (2001) 2001-2009
20. Smith A.P., and Lee N.M. Opioid receptor interactions. local and nonlocal, symmetric and asymmetric, physical and functional. Life Sci 73 (2003) 1873-1893
21. Geber W.F., Lefkowitz S.S., and Hung C.Y. Effect of morphine, hydromorphone, methadone, mescaline, trypan blue, vitamin A, sodium salicylate, and caffeine on the serum interferon level in response to viral infection. Arch Int Pharmacodyn Ther 214 (1975) 322-327
22. Yeager M.P., Procopio M.A., DeLeo J.A., et al. Intravenous fentanyl increases natural killer cell cytotoxicity and circulating CD16(+) lymphocytes in humans. Anesth Analg 94 (2002) 94-99
23. Silbert B.S., Lipkowski A.W., Cepeda M.S., et al. Enhanced potency of receptor-selective opioids after acute burn injury. Anesth Analg 73 (1991) 427-433
24. Meine T.J., Roe M.T., Chen A.Y., et al. Association of intravenous morphine use and outcomes in acute coronary syndromes. Results from the CRUSADE quality improvement initiative. Am Heart J 149 (2005) 1043-1049
25. Choiniere M., Melzack R., Rondeau J., et al. The pain of burns. characteristics and correlates. J Trauma 29 (1989) 1531-1539
26. MacLennan N., Heimbach D.M., and Cullen B.F. Anesthesia for major thermal injury. Anesthesiology 89 (1998) 749-770
27. Santos A.P., Wilson A.K., Hornung C.A., et al. Methamphetamine laboratory explosions. a new and emerging burn injury. J Burn Care Rehabil 26 (2005) 228-232
28. Horn S.D., Wright H.L., Couperus J.J., et al. Association between patient-controlled analgesia pump use and postoperative surgical site infection in intestinal surgery patients. Surgical Infections 3 (2002) 107-108